301211 亨迪藥業
按盤價 
11.110 -0.050 (-0.448%)
11.110 -0.050 (-0.448%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.405 | 1.524 | 3.924 | 7.602 | 5.592 |
| 總資產報酬率 ROA (%) | 0.384 | 1.428 | 3.636 | 6.981 | 5.210 |
| 投入資產回報率 ROIC (%) | 0.400 | 1.507 | 3.871 | 7.409 | 5.477 | 邊際利潤分析 |
| 銷售毛利率 (%) | 20.927 | 22.105 | 28.841 | 40.172 | 28.878 |
| 營業利潤率 (%) | 8.530 | 9.233 | 22.626 | 30.969 | 28.884 |
| 息稅前利潤/營業總收入 (%) | 8.941 | 6.922 | 11.378 | 22.955 | 15.967 |
| 淨利潤/營業總收入 (%) | 7.671 | 7.701 | 20.533 | 26.562 | 24.430 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 10.257 | 32.568 | 78.540 | 96.296 | 94.033 |
| 價值變動淨收益/利潤總額(%) | 72.244 | 70.613 | 18.950 | 1.982 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -0.004 | -1.441 | -0.461 | -1.242 | -0.871 | 償債能力分析 |
| 流動比率 (X) | 17.179 | 15.640 | 11.404 | 11.984 | 10.660 |
| 速動比率 (X) | 15.973 | 14.569 | 10.565 | 10.992 | 10.111 |
| 資產負債率 (%) | 4.901 | 5.356 | 7.191 | 7.457 | 8.895 |
| 帶息債務/全部投入資本 (%) | 0.738 | 0.447 | 0.489 | 0.932 | 2.985 |
| 股東權益/帶息債務 (%) | 13,363.077 | 22,120.754 | 20,215.891 | 10,560.344 | 3,230.841 |
| 股東權益/負債合計 (%) | 1,940.391 | 1,766.998 | 1,290.566 | 1,241.104 | 1,024.271 |
| 利息保障倍數 (X) | 21.768 | -3.175 | -1.021 | -3.007 | -1.260 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 50.762 | 44.513 | 40.804 | 33.696 | 70.748 |
| 存貨周轉天數 (天) | 117.695 | 132.808 | 176.813 | 130.916 | 100.365 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
